Search review questions

Depression response or remission (acute phase, 5 ≤ 12 weeks) · women of any age, with PND up to 12 months

Adverse events · women of any age, with PND up to 12 months

Depression severity ‐ mean EPDS score (acute phase, 5 ≤ 12 weeks) · women of any age, with PND up to 12 months

Treatment acceptability ‐ dropouts · women of any age, with PND up to 12 months

Child‐related outcomes · women of any age, with PND up to 12 months

Depression response or remission (acute phase, 5 ≤ 12 weeks) · women of any age, with PND up to 12 months

Depression remission (acute, 5 ≤ 12 weeks) · women of any age, with PND up to 12 months

Adverse events · women of any age, with PND up to 12 months

Depression severity (acute phase, 5 ≤ 12 weeks) · women of any age, with PND up to 12 months

Treatment acceptability ‐ dropouts · women of any age, with PND up to 12 months

Child‐related outcomes · women of any age, with PND up to 12 months

Depression response (acute phase, 5 ≤ 12 weeks) · women of any age, with PND up to 12 months

Depression remission (acute phase, 5 ≤ 12 weeks) · women of any age, with PND up to 12 months

Adverse events · women of any age, with PND up to 12 months

Depression response (early phase, < 5 weeks) · women of any age, with PND up to 12 months

Depression remission (early phase, < 5 weeks) · women of any age, with PND up to 12 months

Depression severity‐ mean HAM‐D scores (acute phase, 5 ≤ 12 weeks) · women of any age, with PND up to 12 months

Adverse events · women of any age, with PND up to 12 months

Treatment acceptability ‐dropouts · women of any age, with PND up to 12 months

Child‐related outcomes · women of any age, with PND up to 12 months

Depression response (acute phase, 5 ≤ 12 weeks) · women of any age, with PND up to 12 months

Depression remission (acute phase, 5 ≤ 12 weeks) · women of any age, with PND up to 12 months

Adverse events · women of any age, with PND up to 12 months

Depression severity · women of any age, with PND up to 12 months

Treatment acceptability · women of any age, with PND up to 12 months

Child‐related outcomes · women of any age, with PND up to 12 months

Depression severity ‐ overall (acute, 5 ≤ 12 weeks) · women of any age, with PND up to 12 months

Depression severity ‐ EPDS (acute, 5 ≤ 12 weeks) · women of any age, with PND up to 12 months

Treatment acceptability ‐ dropouts · women of any age, with PND up to 12 months

Child‐related outcomes · women of any age, with PND up to 12 months

Depression response or remission (acute, 5 ≤ 12 weeks) · women of any age, with PND up to 12 months

Adverse events · women of any age, with PND up to 12 months

Recurrence of any episodes at one year (hospitalization for any episodes) · bipolar disorder

Recurrence of manic episode at one year · bipolar disorder

Recurrence of depressive episode at one year · bipolar disorder

Quality of life as measured by the 36‐Item Short Form Health Survey · bipolar disorder

Total severity score from depression and mania symptom scores, such as HDRS and the YMRS · bipolar disorder

Recurrence of any episodes at one year (hospitalization for any episodes) · bipolar disorder

Recurrence of any episodes at one year (Young Mania Rating Scale (YMRS) total score ≥15 for manic episode) · bipolar disorder

Recurrence of any episodes at one year (Montgomery‐Asberg Depression Rating Scale (MADRS) total score ≥15 for depressive episode; Hamilton Depression Rating Scale (HDRS) total score ≥14 for depressive episode) · bipolar disorder

Recurrence of any episodes at one year for clinical worsening with additional psychotropics (mood stabilizers, antidepressants, antipsychotics or benzodiazepines) · bipolar disorder

Recurrence of any episodes at one year (active suicidal behavior) · bipolar disorder

Withdrawal from treatment due to any reason, up to 12 weeks after intervention commencement (short term) · bipolar disorder

Recurrence of any episodes at one year (Young Mania Rating Scale (YMRS) total score ≥15 for manic episode) · bipolar disorder

Withdrawal from treatment due to any reason, 6‐12 months after intervention initiation (long term) · bipolar disorder

Any reported adverse effects up to 12 weeks after starting treatment (short term) · bipolar disorder

Any reported adverse effects 6‐12 months after initiating the intervention (long term) · bipolar disorder

Recurrence of manic episode at one year · bipolar disorder

Recurrence of depressive episode at one year · bipolar disorder

Quality of life as measured by the 36‐Item Short Form Health Survey · bipolar disorder